CLDF Title
Home | Contact Us | Bookmark
MASH HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
Embassy of Education
Webcasts Abstract Library LiverQ Academy National Conference Regional Conferences
 
HCV | WEBCAST Back
Webcasts
 
  Release Date 12/6/2012
Expiration Date 12/6/2013
This program has expired. CME credit is no longer available.
     
  Nezam Afdhal, MD
Beth Israel Deaconess
Medical Center
Boston, MA
 
   
     
  Kim Brown, MD
Henry Ford Hospital
Detroit, MI
 
   
     
  Jordan Feld, MD
Toronto Western Hospital
Liver Center
Toronto, Canada
 
   
     
  Michael Fried, MD
University of North Carolina
Chapel Hill, NC
 
   
     
  Ira Jacobson, MD
Weill Cornell Medical College
New York, NY
 
   
     
     
   
     
  Presented for attendees of the 63rd AASLD Annual Meeting (or The Liver Meeting®). This event/function is sponsored by Chronic Liver Disease Foundation and Supported by Vertex Pharmaceuticals. This is not an official function/event of the American Association for the Study of Liver Diseases.  
     
 
Jordan Feld, MD
Toronto Western Hospital Liver Center
Toronto, Canada
Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld completed a clinical research fellowship in hepatology after which he spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health.

Dr. Feld returned to Toronto to join the faculty of the University of Toronto as an Assistant Professor of Medicine and clinician-scientist based at the Toronto Western Hospital Liver Center and the Sandra Rotman Centre for Global Health. His laboratory work focuses on understanding treatment non-response in hepatitis C infection and, more broadly, on understanding the antiviral immune response with the goal of developing new strategies for the treatment of viral hepatitis.

Speaker Disclosure:
Jordan Feld, MD, has served as a consultant for and has participated on the speaker’s bureaus for Abbott, Gilead, Merck, Roche, and Vertex. He has participated on the advisory boards for Abbott, BI, Gilead, Merck, Roche, and Vertex.
 

Subscribe

Be the first to know about our latest upcoming programs and events!

CLDF

Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.